Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress - BioDrugs Autoimmune diseases are highly prevalent and affect people at all ages, women more often than men. The most prominent immunological manifestation is the production of antibodies directed against self-...

New publication that provides important perspectives on new treatment methods for #autoimmune diseases, particularly by focusing on diffuse mechanisms involving #FcRn.
With Inger Sandlie from @biovitenskap.bsky.social
Published in BioDrugs by @springernature.com
link.springer.com/article/10.1...

Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress - BioDrugs Autoimmune diseases are highly prevalent and affect people at all ages, women more often than men. The most prominent immunological manifestation is the production of antibodies directed against self-...

Targeting the #FcRn in #AutoimmuneDiseases: Pipeline & Progress

Torleif Tollefsrud Gjølberg & Colleagues Dig Deep into the Biology of the Neonatal Fc Receptor & its Antagonism in Superlative Breaking Open Access Review

#Nipocalimab, an immunoselective #FcRn blocker that lowers #IgG and has unique molecular properties

#autoimmunity #alloimmunity #therapeuticantibodies

Breaking study from @johnsonandjohnson.bsky.social

www.tandfonline.com/doi/full/10....